Fruquintinib Combined With TAS102 for Advanced Gastric Cancer

NCT06102785 · clinicaltrials.gov ↗

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: Fruquintinib, TAS102

Sponsor

Tianjin Medical University Cancer Institute and Hospital